Sean A Cassidy's Net Worth

$12 Million

Estimate Recalculated Sep 9, 2024 12:25AM EST

Who is Sean A Cassidy

Sean A Cassidy has an estimated net worth of $12 Million. This is based on reported shares across multiple companies, which include ARVINAS, INC., CURAGEN CORP, and HOOKIPA Pharma Inc..

SEC CIK

Sean A Cassidy's CIK is 0001421914

Past Insider Trading and Trends

2018 was Sean A Cassidy's most active year for acquiring shares with 8 total transactions. Sean A Cassidy's most active month to acquire stocks was the month of January. 2021 was Sean A Cassidy's most active year for disposing of shares, totalling 18 transactions. Sean A Cassidy's most active month to dispose stocks was the month of January. 2021 saw Sean A Cassidy paying a total of $1,201,520.00 for 147,887 shares, this is the most they've acquired in one year. In 2021 Sean A Cassidy cashed out on 156,309 shares for a total of $6,238,323.13, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ARVINAS, INC.

Chief Financial Officer
Updated Feb 27, 2024
Form 4
-0.93%
-1.70K
$47.05
-$80.08K
Feb 27, 2024
181.92K
Sale
Feb 23
Form 4
-0.94%
-1.75K
$29.53
-$51.53K
Mar 03, 2023
183.62K
Sale
Mar 01
Form 4
47.43%
76.58K
Feb 24, 2023
238.02K
Grant
Feb 22
Form 4
-7.77%
-15.00K
$29.50
-$1.05M
Mar 15, 2022
178.16K
Sale
ScheduledMar 11
Form 4
38.97%
65.41K
$63.94
-$101.86K
Mar 04, 2022
233.24K
Sell-Options
Feb 23 - Mar 04
Form 4
-7.99%
-15.00K
$43.00
-$810.00K
Dec 21, 2021
172.63K
Sale
ScheduledDec 17
Form 4
-8.42%
-17.24K
$58.00
-$1.45M
Jul 30, 2021
187.63K
Sale
ScheduledJul 28
Form 4
64.46%
65.78K
$77.45
-$172.02K
Mar 02, 2021
167.83K
Sell-Options
Feb 26 - Mar 02
Form 4
$16.00
$14.30K
Feb 18, 2021
179.00K
Options
Feb 17
Form 4
-17.27%
-41.96K
$47.23
-$2.62M
Feb 18, 2021
201.05K
Sale
ScheduledFeb 16
Form 4
$16.00
$48.10K
Nov 12, 2020
179.00K
Options
Nov 09
Form 4
$16.00
$21.70K
May 14, 2020
179.00K
Options
May 13
Form 4
-6.23%
-10.00K
$60.00
-$600.00K
May 14, 2020
150.42K
Sale
ScheduledMay 12
Form 4
$16.00
$128.48K
Mar 24, 2020
195.81K
Options
Mar 23
Form 4
-0.90%
-1.51K
$37.61
-$56.94K
Mar 23, 2020
166.77K
Sale
Mar 19
Form 4
75.00K
Mar 02, 2020
75.00K
Grant
Feb 27
Form 4
-6.28%
-10.00K
$51.02
-$510.16K
Feb 11, 2020
149.12K
Sale
ScheduledFeb 07
Form 4
-5.91%
-10.00K
$32.00
-$320.00K
Nov 21, 2019
159.12K
Sale
ScheduledNov 19
Form 4
$16.00
$100.00K
Aug 09, 2019
185.21K
Options
Aug 07
Form 4
-6.83%
-11.95K
$26.22
-$313.25K
Jul 31, 2019
162.87K
Sale
ScheduledJul 29
Form 4
106.92K
Mar 05, 2019
106.92K
Grant
Mar 01
Form 4
-5.63%
-10.43K
$16.00
Oct 03, 2018
174.81K
Buy-Options
Oct 01
Form 4
163.15K
Sep 28, 2018
163.15K
Grant
Sep 26
Form 3
Sep 26, 2018
167.87K
Showing 24 results

CURAGEN CORP

Former VP & CFO
Updated Oct 05, 2009
Form 4
-100.00%
-259.60K
Oct 05, 2009
Disposition
Oct 01
Form 4
159.60K
$0.68
$108.53K
Jan 22, 2009
159.60K
Grant
Jan 20
Form 4
100.00K
$0.69
$69.00K
Jan 28, 2008
100.00K
Grant
Jan 24
Form 3
Jan 03, 2008
Showing 4 results

HOOKIPA Pharma Inc.

Investor
Updated Jul 24, 2024
Form 4
9.80K
Jul 24, 2024
9.80K
Grant
Jul 22
Form 3
Jul 24, 2024
Showing 2 results